CSPHF
Price
$0.23
Change
+$0.03 (+15.00%)
Updated
Nov 22 closing price
DVHGF
Price
$0.14
Change
+$0.02 (+16.67%)
Updated
Dec 6 closing price
Ad is loading...

CSPHF vs DVHGF

Header iconCSPHF vs DVHGF Comparison
Open Charts CSPHF vs DVHGFBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.23
Change+$0.03 (+15.00%)
Volume$5.8K
CapitalizationN/A
Devonian Health Group
Price$0.14
Change+$0.02 (+16.67%)
Volume$3.5K
CapitalizationN/A
CSPHF vs DVHGF Comparison Chart
Loading...
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVHGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. DVHGF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Sell and DVHGF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CSPHF: $0.23 vs. DVHGF: $0.14)
Brand notoriety: CSPHF and DVHGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 2% vs. DVHGF: 265%
Market capitalization -- CSPHF: $420.16M vs. DVHGF: $20.96M
CSPHF [@Biotechnology] is valued at $420.16M. DVHGF’s [@Biotechnology] market capitalization is $20.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileDVHGF’s FA Score has 1 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • DVHGF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CSPHF and DVHGF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSPHF’s TA Score shows that 4 TA indicator(s) are bullish while DVHGF’s TA Score has 3 bullish TA indicator(s).

  • CSPHF’s TA Score: 4 bullish, 3 bearish.
  • DVHGF’s TA Score: 3 bullish, 0 bearish.
According to our system of comparison, DVHGF is a better buy in the short-term than CSPHF.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while DVHGF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($420M) has a higher market cap than DVHGF($21M). CSPHF YTD gains are higher at: -29.751 vs. DVHGF (-33.863).
CSPHFDVHGFCSPHF / DVHGF
Capitalization420M21M2,000%
EBITDAN/A-2.32M-
Gain YTD-29.751-33.86388%
P/E RatioN/AN/A-
RevenueN/A9.75M-
Total CashN/A3.51M-
Total DebtN/A2.18M-
TECHNICAL ANALYSIS
Technical Analysis
CSPHFDVHGF
RSI
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
42%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
41%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
33%
Bullish Trend 2 days ago
10%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
24%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Ad is loading...
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVHGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CANC25.560.17
+0.69%
Tema Oncology ETF
CSHI49.970.01
+0.03%
NEOS Enhanced Income CA Alt ETF
XDAT27.21N/A
N/A
Franklin Exponential Data ETF
BSMT23.12-0.06
-0.26%
Invesco BulletShares 2029 Muncpl Bd ETF
KBWB67.08-1.00
-1.47%
Invesco KBW Bank ETF

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
WINT - CSPHF
24%
Poorly correlated
-3.77%
BCAB - CSPHF
9%
Poorly correlated
-2.96%
SIGY - CSPHF
8%
Poorly correlated
-30.00%
NBTX - CSPHF
7%
Poorly correlated
+1.43%
More

DVHGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with CSPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then CSPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVHGF
1D Price
Change %
DVHGF100%
N/A
CSPHF - DVHGF
38%
Loosely correlated
N/A
WINT - DVHGF
38%
Loosely correlated
-3.77%
JAGX - DVHGF
27%
Poorly correlated
+2.62%
RNAZ - DVHGF
25%
Poorly correlated
-6.17%
HMTXF - DVHGF
21%
Poorly correlated
-0.23%
More